EUPRAXIA PHARMACEUTICALS INC (EPRX) Institutional Shareholders
EUPRAXIA PHARMACEUTICALS INC (EPRX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $154.12M in EPRX holdings during the latest filing period.
Beutel, Goodman & Co Ltd. is currently the largest disclosed institutional shareholder of EPRX tracked by InsiderSet, reporting ownership valued at approximately $23.81M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $31.13M, representing an estimated gain of +30.75% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 61% of the total disclosed EPRX value among the investors covered in this analysis. Major shareholders include Beutel, Goodman & Co Ltd., Affinity Asset Advisors, Llc, Balyasny Asset Management L.P., and several other long-term asset managers with concentrated positions in EUPRAXIA PHARMACEUTICALS INC (EPRX).
This page ranks the largest institutional EPRX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
64
Total Reported Value
$154.12M
Largest Holder
Beutel, Goodman & Co Ltd.
Largest Position
$23.81M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
72
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 0.18% | 3,627,864 | $23,806,000 | $31,127,073 | +$7,321,073 | +30.75% | |
| Affinity Asset Advisors, Llc | 0.53% | 1,650,000 | $10,906,500 | $14,157,000 | +$3,250,500 | +29.80% | |
| Balyasny Asset Management L.P. | 0.02% | 1,350,015 | $8,923,599 | $11,583,129 | +$2,659,530 | +29.80% | |
| Vivo Capital, Llc | 0.81% | 1,350,000 | $8,923,500 | $11,583,000 | +$2,659,500 | +29.80% | |
| Scotia Capital Inc. | 0.03% | 1,343,726 | $8,782,272 | $11,529,169 | +$2,746,897 | +31.28% | |
| Pfm Health Sciences, Lp | 0.69% | 1,210,661 | $8,002,469 | $10,387,471 | +$2,385,002 | +29.80% | |
| Great Point Partners Llc | 1.87% | 1,200,000 | $7,932,000 | $10,296,000 | +$2,364,000 | +29.80% | |
| Rubric Capital Management Lp | 0.05% | 867,424 | $5,733,673 | $7,442,498 | +$1,708,825 | +29.80% | |
| Ikarian Capital, Llc | 0.88% | 809,741 | $5,352,388 | $6,947,578 | +$1,595,190 | +29.80% | |
| Woodline Partners Lp | 0.02% | 746,864 | $4,936,771 | $6,408,093 | +$1,471,322 | +29.80% | |
| Point72 Asset Management, L.P. | 0.01% | 730,284 | $4,827,716 | $6,265,837 | +$1,438,121 | +29.79% | |
| Ameriprise Financial Inc | 0.00% | 711,024 | $4,699,869 | $6,100,586 | +$1,400,717 | +29.80% | |
| Redmile Group, Llc | 0.27% | 611,400 | $4,041,354 | $5,245,812 | +$1,204,458 | +29.80% | |
| Seven Fleet Capital Management Lp | 0.67% | 610,785 | $4,037,289 | $5,240,535 | +$1,203,246 | +29.80% | |
| Ubs Group Ag | 0.00% | 519,211 | $3,431,984 | $4,454,830 | +$1,022,846 | +29.80% | |
| Citadel Advisors Llc | 0.00% | 502,011 | $3,318,292 | $4,307,254 | +$988,962 | +29.80% | |
| Millennium Management Llc | 0.00% | 441,586 | $2,918,796 | $3,788,808 | +$870,012 | +29.81% | |
| Alyeska Investment Group, L.P. | 0.01% | 375,000 | $2,478,750 | $3,217,500 | +$738,750 | +29.80% | |
| Picton Mahoney Asset Management | 0.02% | 360,878 | $2,385,404 | $3,096,333 | +$710,929 | +29.80% | |
| Velan Capital Investment Management Lp | 1.43% | 352,000 | $2,326,720 | $3,020,160 | +$693,440 | +29.80% | |
| Jane Street Group, Llc | 0.00% | 329,053 | $2,157,990 | $2,823,275 | +$665,285 | +30.83% | |
| Aisling Capital Management Lp | 0.46% | 325,000 | $2,148,250 | $2,788,500 | +$640,250 | +29.80% | |
| Summittx Capital, L.P. | 0.06% | 318,784 | $2,107,162 | $2,735,167 | +$628,005 | +29.80% | |
| Royal Bank Of Canada | 0.00% | 311,435 | $2,058,000 | $2,672,112 | +$614,112 | +29.84% | |
| Orbimed Advisors Llc | 0.03% | 269,000 | $1,778,090 | $2,308,020 | +$529,930 | +29.80% | |
| Bank Of America Corp | 0.00% | 264,721 | $1,749,806 | $2,271,306 | +$521,500 | +29.80% | |
| Ally Bridge Group (Ny) Llc | 2.15% | 252,175 | $1,666,877 | $2,163,662 | +$496,785 | +29.80% | |
| Cibc World Market Inc. | 0.00% | 234,673 | $1,539,137 | $2,013,494 | +$474,357 | +30.82% | |
| Dafna Capital Management Llc | 0.28% | 225,600 | $1,491,216 | $1,935,648 | +$444,432 | +29.80% | |
| Two Sigma Investments, Lp | 0.00% | 221,084 | $1,461,365 | $1,896,901 | +$435,536 | +29.80% | |
| Boothbay Fund Management, Llc | 0.03% | 212,653 | $1,405,636 | $1,824,563 | +$418,927 | +29.80% | |
| Marshall Wace, Llp | 0.00% | 158,133 | $1,045,257 | $1,356,781 | +$311,524 | +29.80% | |
| Td Waterhouse Canada Inc. | 0.00% | 79,607 | $534,915 | $683,028 | +$148,113 | +27.69% | |
| Xtx Topco Ltd | 0.01% | 70,265 | $464,452 | $602,874 | +$138,422 | +29.80% | |
| Ingalls & Snyder Llc | 0.01% | 68,450 | $452,000 | $587,301 | +$135,301 | +29.93% | |
| Annis Gardner Whiting Capital Advisors, Llc | 0.06% | 60,000 | $396,600 | $514,800 | +$118,200 | +29.80% | |
| Goldman Sachs Group Inc | 0.00% | 58,058 | $383,763 | $498,138 | +$114,375 | +29.80% | |
| Raymond James Financial Inc | 0.00% | 53,503 | $353,655 | $459,056 | +$105,401 | +29.80% | |
| 1832 Asset Management L.P. | 0.00% | 50,432 | $333,356 | $432,707 | +$99,351 | +29.80% | |
| Bnp Paribas Financial Markets | 0.00% | 46,145 | $305,018 | $395,924 | +$90,906 | +29.80% | |
| Stonepine Capital Management, Llc | 0.22% | 43,491 | $287,476 | $373,153 | +$85,677 | +29.80% | |
| Bank Of Montreal | 0.00% | 38,457 | $252,195 | $329,961 | +$77,766 | +30.84% | |
| Geode Capital Management, Llc | 0.00% | 36,211 | $239,354 | $310,690 | +$71,336 | +29.80% | |
| Brevan Howard Capital Management Lp | 0.00% | 34,767 | $229,810 | $298,301 | +$68,491 | +29.80% | |
| Qube Research & Technologies Ltd | 0.00% | 34,237 | $226,307 | $293,753 | +$67,446 | +29.80% | |
| Toronto Dominion Bank | 0.00% | 30,920 | $202,769 | $265,294 | +$62,525 | +30.84% | |
| Axq Capital, Lp | 0.02% | 21,150 | $139,802 | $181,467 | +$41,665 | +29.80% | |
| Jump Financial, Llc | 0.00% | 19,800 | $130,878 | $169,884 | +$39,006 | +29.80% | |
| Natixis | 0.00% | 17,644 | $115,215 | $151,386 | +$36,171 | +31.39% | |
| Jpmorgan Chase & Co | 0.00% | 14,186 | $93,486 | $121,716 | +$28,230 | +30.20% |
Frequently asked questions about EPRX
Who owns the most EPRX stock?
The largest holders of EPRX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for EUPRAXIA PHARMACEUTICALS INC (EPRX).
Is EPRX widely held by superinvestors?
Many widely followed stocks like EPRX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly EPRX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.